WO2025219231 - DESIGN OF ANTIBODIES TARGETING A SPECIFIC EPITOPE

National phase entry is expected:
Publication Number WO/2025/219231
Publication Date 23.10.2025
International Application No. PCT/EP2025/059986
International Filing Date 11.04.2025
Title **
[English] DESIGN OF ANTIBODIES TARGETING A SPECIFIC EPITOPE
[French] D'ANTICORPS CIBLANT UN ÉPITOPE SPÉCIFIQUE
Applicants **
VIB VZW
KATHOLIEKE UNIVERSITEIT LEUVEN
FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (CRG)
INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA)
Inventors
ROUSSEAU, Frederic
SCHYMKOWITZ, Joost
VAN DER KANT, Rob
ZHANG, Zhongyao
DEWILDE, Maarten
SERRANO PUBUL, Luis
DELGADO BLANCO, Francisco Javier
CIANFERONI, Damiano
Priority Data
24170283.6   15.04.2024   EP
24382431.5   22.04.2024   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2125
EPO Filing, Examination, Granting8875
Japan Filing, Examination, Granting1877
South Korea Filing, Examination, Granting1538
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 19,155
Contact Us
Abstract[English] The present invention relates to methods and systems which relate to the biomedical field and relate to subfields of computational biology and bioinformatics. More, specifically the invention provides a computer-implemented algorithm which can produce a panel of antibodies directed to an epitope of choice.[French] La présente invention concerne des procédés et des systèmes qui se rapportent au domaine biomédical et se rapportent à des sous-domaines de la biologie computationnelle et de la bioinformatique. Plus particulièrement, l'invention concerne un algorithme mis en œuvre par ordinateur qui peut produire un panel d'anticorps dirigés contre un épitope de choix.